GW Pharmaceuticals PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other
miscellaneous service companies in North America:
Opiant Pharmaceuticals Inc
sales of 13.09 million Canadian Dollars [US$9.87 million]
of which 67%
was Collaborative), and
Neptune Technologies & Bioressources Inc
based in Canada
(22.63 million Canadian Dollars [US$17.06 million]
Sales fell dramatically in 2016:
GW Pharmaceuticals PLC reported sales of $14.57 million
September of 2016.
decrease of 66.9%
versus 2015, when the company's sales were $43.99 million.